INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V959. A total of 4 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | -99.4% | 50 | -85.3% | 0.00% | – |
| Q1 2019 | $156,000 | +1460.0% | 339 | +1030.0% | 0.00% | – |
| Q4 2018 | $10,000 | -82.1% | 30 | -46.4% | 0.00% | – |
| Q3 2018 | $56,000 | -69.6% | 56 | -78.0% | 0.00% | -100.0% |
| Q2 2018 | $184,000 | +327.9% | 255 | +165.6% | 0.00% | -50.0% |
| Q1 2018 | $43,000 | +2050.0% | 96 | +209.7% | 0.00% | – |
| Q4 2017 | $2,000 | -75.0% | 31 | +138.5% | 0.00% | – |
| Q3 2017 | $8,000 | -11.1% | 13 | -81.9% | 0.00% | – |
| Q2 2017 | $9,000 | -64.0% | 72 | -6.5% | 0.00% | -100.0% |
| Q1 2017 | $25,000 | -74.2% | 77 | -89.7% | 0.00% | -83.3% |
| Q4 2016 | $97,000 | +64.4% | 746 | +193.7% | 0.01% | +50.0% |
| Q3 2016 | $59,000 | -44.9% | 254 | -30.0% | 0.00% | -42.9% |
| Q2 2016 | $107,000 | +69.8% | 363 | -15.0% | 0.01% | +40.0% |
| Q1 2016 | $63,000 | +6.8% | 427 | +577.8% | 0.01% | 0.0% |
| Q4 2015 | $59,000 | -19.2% | 63 | -33.0% | 0.01% | 0.0% |
| Q3 2015 | $73,000 | +14.1% | 94 | -69.5% | 0.01% | 0.0% |
| Q2 2015 | $64,000 | – | 308 | +30700.0% | 0.01% | – |
| Q4 2014 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Thrax Management, LLC | 10,000 | $160,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 58,100 | $929,000 | 0.01% |
| SIMPLEX TRADING, LLC | 427 | $63,000 | 0.01% |
| Citadel Advisors | 11,100 | $177,000 | 0.00% |